Drug Discovery's Blind Spot: Why Organoid-Artificial Intelligence Convergence Demands Integrated Governance.
Organoid-artificial intelligence (AI) platforms are increasingly central to drug discovery, yet they sit between two governance regimes. AI frameworks presume stable, well-characterized inputs, while organoid ethics focuses on donor consent, moral status, and tissue use, leaving downstream computational uses of organoi...